This isn’t 20/20 GeneSystems’s most recent raise. Reg CF · Convertible Note · Oct 2025 (Closed) is more current.View latest round

Reg A+ · Preferred Stock · Mar 2018

ClosedReg A+Preferred Equity

via StartEngine · last checked Sep 25, 2026View campaign

Raised

—

Investors

—

Estimated pre-money

$23.3M

—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$23.3M

Price / share$3.53

Estimated, not stated: $3.53 × 6,590,788 securities outstanding as of Mar 9, 2018 (Form 1-A filed Mar 9, 2018).

Offering details

Target—

Max—

Min investment—

OpenedMar 9, 2018

Deadline—

Days active3,136

Links & provenance

Campaign page

Source: Manual
Last synced Sep 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.